장기 보존 시장(2026-2030년)

The global organ preservation market is forecasted to grow by USD 134639.9 thousand during 2025-2030, accelerating at a CAGR of 7.2% during the forecast period. The report on the global organ preservation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological advancements in machine perfusion systems, rising prevalence of organ failure, supportive government initiatives and policies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global organ preservation market is segmented as below:

By Type

• Living organ donation
• Deceased organ donation

By End-User

• Hospitals and clinics
• Organ banks
• Others

By Technique

• Static cold storage
• Hypothermic machine perfusion
• Normothermic machine perfusion

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the expansion of ex vivo technology as one of the prime reasons driving the global organ preservation market growth during the next few years. Also, strategic industry collaborations and partnerships and integration of ai systems and advanced digital monitoring tools will lead to sizable demand in the market.

The report on the global organ preservation market covers the following areas:

• Global organ preservation market sizing
• Global organ preservation market forecast
• Global organ preservation market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global organ preservation market vendors that include 21st Century Medicine, Accord Healthcare Ltd., Artivion Inc., B.Braun SE, BioLife Solutions Inc., Bridge to Life Ltd., Carnamedica, CytoSorbents Corp., EBERS Medical Technology SL, Global Transplant Solutions, Institut Georges Lopez, Organ Recovery Systems Inc., OrganOx Ltd., Paragonix Technologies Inc., Preservation Solution Inc., TransMedics Inc., XVIVO Perfusion AB. Also, the global organ preservation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Market Segmentation by Technique
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Organ Preservation Market 2020 - 2024
  • Historic Market Size - Data Table on Global Organ Preservation Market 2020 - 2024 ($ thousand)
• 5.2 Type segment analysis 2020 - 2024
  • Historic Market Size - Type Segment 2020 - 2024 ($ thousand)
• 5.3 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ thousand)
• 5.4 Technique segment analysis 2020 - 2024
  • Historic Market Size - Technique Segment 2020 - 2024 ($ thousand)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ thousand)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ thousand)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Organ Preservation Market
• 6.2 Impact of geopolitical conflicts on Global Organ Preservation Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Type

• 8.1 Market segments
• 8.2 Comparison by Type
• 8.3 Living organ donation - Market size and forecast 2025-2030
• 8.4 Deceased organ donation - Market size and forecast 2025-2030
• 8.5 Market opportunity by Type
  • Market opportunity by Type ($ thousand)

9 Market Segmentation by End-user

• 9.1 Market segments
• 9.2 Comparison by End-user
• 9.3 Hospitals and clinics - Market size and forecast 2025-2030
• 9.4 Organ banks - Market size and forecast 2025-2030
• 9.5 Others - Market size and forecast 2025-2030
• 9.6 Market opportunity by End-user
  • Market opportunity by End-user ($ thousand)

10 Market Segmentation by Technique

• 10.1 Market segments
• 10.2 Comparison by Technique
• 10.3 Static cold storage - Market size and forecast 2025-2030
• 10.4 Hypothermic machine perfusion - Market size and forecast 2025-2030
• 10.5 Normothermic machine perfusion - Market size and forecast 2025-2030
• 10.6 Market opportunity by Technique
  • Market opportunity by Technique ($ thousand)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Colombia - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ thousand)
  • Data Tables on Market opportunity by geography ($ thousand)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Technological advancements in machine perfusion systems
  • Rising prevalence of organ failure
  • Supportive government initiatives and policies
• 13.2 Market challenges
  • Severe donor organ shortage and supply-demand imbalance
  • Prohibitive capital costs and complex logistics infrastructure
  • Stringent regulatory frameworks and lengthy commercialization timelines
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Expansion of ex vivo technology
  • Strategic industry collaborations and partnerships
  • Integration of AI systems and advanced digital monitoring tools

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 21st Century Medicine
  • 21st Century Medicine - Overview
  • 21st Century Medicine - Product / Service
  • 21st Century Medicine - Key offerings
  • SWOT
• 15.5 Accord Healthcare Ltd.
  • Accord Healthcare Ltd. - Overview
  • Accord Healthcare Ltd. - Product / Service
  • Accord Healthcare Ltd. - Key offerings
  • SWOT
• 15.6 Artivion Inc.
  • Artivion Inc. - Overview
  • Artivion Inc. - Business segments
  • Artivion Inc. - Key offerings
  • Artivion Inc. - Segment focus
  • SWOT
• 15.7 B.Braun SE
  • B.Braun SE - Overview
  • B.Braun SE - Product / Service
  • B.Braun SE - Key offerings
  • SWOT
• 15.8 BioLife Solutions Inc.
  • BioLife Solutions Inc. - Overview
  • BioLife Solutions Inc. - Product / Service
  • BioLife Solutions Inc. - Key offerings
  • SWOT
• 15.9 Bridge to Life Ltd.
  • Bridge to Life Ltd. - Overview
  • Bridge to Life Ltd. - Product / Service
  • Bridge to Life Ltd. - Key offerings
  • SWOT
• 15.10 Carnamedica
  • Carnamedica - Overview
  • Carnamedica - Product / Service
  • Carnamedica - Key offerings
  • SWOT
• 15.11 EBERS Medical Technology SL
  • EBERS Medical Technology SL - Overview
  • EBERS Medical Technology SL - Product / Service
  • EBERS Medical Technology SL - Key offerings
  • SWOT
• 15.12 Global Transplant Solutions
  • Global Transplant Solutions - Overview
  • Global Transplant Solutions - Product / Service
  • Global Transplant Solutions - Key offerings
  • SWOT
• 15.13 Institut Georges Lopez
  • Institut Georges Lopez - Overview
  • Institut Georges Lopez - Product / Service
  • Institut Georges Lopez - Key offerings
  • SWOT
• 15.14 Organ Recovery Systems Inc.
  • Organ Recovery Systems Inc. - Overview
  • Organ Recovery Systems Inc. - Product / Service
  • Organ Recovery Systems Inc. - Key offerings
  • SWOT
• 15.15 OrganOx Ltd.
  • OrganOx Ltd. - Overview
  • OrganOx Ltd. - Product / Service
  • OrganOx Ltd. - Key offerings
  • SWOT
• 15.16 Paragonix Technologies Inc.
  • Paragonix Technologies Inc. - Overview
  • Paragonix Technologies Inc. - Product / Service
  • Paragonix Technologies Inc. - Key offerings
  • SWOT
• 15.17 TransMedics Inc.
  • TransMedics Inc. - Overview
  • TransMedics Inc. - Product / Service
  • TransMedics Inc. - Key offerings
  • SWOT
• 15.18 XVIVO Perfusion AB
  • XVIVO Perfusion AB - Overview
  • XVIVO Perfusion AB - Business segments
  • XVIVO Perfusion AB - Key offerings
  • XVIVO Perfusion AB - Segment focus
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations